Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
株式のランク #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
株価
$11.14
最終同期: 2023-11-28
時価総額
$160.14M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Monterey Bio Acquisition Corporation (MTRY)

カテゴリー

Monterey Bio Acquisition Corporation(MTRY)の配当利回りの履歴
Monterey Bio Acquisition Corporation(銘柄コード: MTRY)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Monterey Bio Acquisition Corporation(MTRY)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)